A novel role of IL-15 in the development of osteoclasts: Inability to replace its activity with IL-2

Yoshiyasu Ogata, Akiko Kukita, Toshio Kukita, Mitunori Komine, Akira Miyahara, Sumio Miyazaki, Osamu Kohashi

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

IL-15 shares many activities with IL-2 on stimulating lymphocytes, hematopoietic progenitor cells, and macrophages. However, the role of IL-15 in osteoclastogenesis has not been elucidated. The recent finding of abundant IL-15 in rheumatoid arthritis synovial fluids suggested a possible role for this cytokine in the pathological destruction of bone and prompted us to determine whether IL-15 stimulates osteoclast formation. IL-15 stimulated the formation of multinucleated osteoclast-like cells in rat bone marrow cultures. In stroma-free cultures, IL-15 increased the number of mononuclear preosteoclast-like cells in the early stage of osteoclast formation. The stimulation was observed even after treatment with IL-15 for only 24 or 48 h of culture. Moreover, low IL-15 concentration (0.1 ng/ml) strongly increased the level of calcitonin receptor mRNA of mononuclear preosteoclast-like cells. Although IL-15 is known as a potent stimulator of TNF-α, its activity was not abolished by addition of anti-TNF-α Ab. Interestingly, IL-2 and IL- 7, which utilize some IL-15R components, had no effect on osteoclast differentiation, but pretreatment with IL-2 or IL-7 of bone marrow cells before the addition of IL-15 inhibited the enhancing activity of IL-15. In summary, IL-15 has a novel activity to stimulate the differentiation of osteoclast progenitors into preosteoclasts, which cannot be replaced by IL-2 but may use components in common with IL-2R to mediate its effects.

Original languageEnglish
Pages (from-to)2754-2760
Number of pages7
JournalJournal of Immunology
Volume162
Issue number5
Publication statusPublished - Mar 1 1999

Fingerprint

Interleukin-15
Osteoclasts
Interleukin-2
Interleukin-7
Calcitonin Receptors
Synovial Fluid
Hematopoietic Stem Cells
Osteogenesis
Bone Marrow Cells
Rheumatoid Arthritis

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Ogata, Y., Kukita, A., Kukita, T., Komine, M., Miyahara, A., Miyazaki, S., & Kohashi, O. (1999). A novel role of IL-15 in the development of osteoclasts: Inability to replace its activity with IL-2. Journal of Immunology, 162(5), 2754-2760.

A novel role of IL-15 in the development of osteoclasts : Inability to replace its activity with IL-2. / Ogata, Yoshiyasu; Kukita, Akiko; Kukita, Toshio; Komine, Mitunori; Miyahara, Akira; Miyazaki, Sumio; Kohashi, Osamu.

In: Journal of Immunology, Vol. 162, No. 5, 01.03.1999, p. 2754-2760.

Research output: Contribution to journalArticle

Ogata, Y, Kukita, A, Kukita, T, Komine, M, Miyahara, A, Miyazaki, S & Kohashi, O 1999, 'A novel role of IL-15 in the development of osteoclasts: Inability to replace its activity with IL-2', Journal of Immunology, vol. 162, no. 5, pp. 2754-2760.
Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, Miyazaki S et al. A novel role of IL-15 in the development of osteoclasts: Inability to replace its activity with IL-2. Journal of Immunology. 1999 Mar 1;162(5):2754-2760.
Ogata, Yoshiyasu ; Kukita, Akiko ; Kukita, Toshio ; Komine, Mitunori ; Miyahara, Akira ; Miyazaki, Sumio ; Kohashi, Osamu. / A novel role of IL-15 in the development of osteoclasts : Inability to replace its activity with IL-2. In: Journal of Immunology. 1999 ; Vol. 162, No. 5. pp. 2754-2760.
@article{0d385a49ec9744bbb0d83e9449e149ca,
title = "A novel role of IL-15 in the development of osteoclasts: Inability to replace its activity with IL-2",
abstract = "IL-15 shares many activities with IL-2 on stimulating lymphocytes, hematopoietic progenitor cells, and macrophages. However, the role of IL-15 in osteoclastogenesis has not been elucidated. The recent finding of abundant IL-15 in rheumatoid arthritis synovial fluids suggested a possible role for this cytokine in the pathological destruction of bone and prompted us to determine whether IL-15 stimulates osteoclast formation. IL-15 stimulated the formation of multinucleated osteoclast-like cells in rat bone marrow cultures. In stroma-free cultures, IL-15 increased the number of mononuclear preosteoclast-like cells in the early stage of osteoclast formation. The stimulation was observed even after treatment with IL-15 for only 24 or 48 h of culture. Moreover, low IL-15 concentration (0.1 ng/ml) strongly increased the level of calcitonin receptor mRNA of mononuclear preosteoclast-like cells. Although IL-15 is known as a potent stimulator of TNF-α, its activity was not abolished by addition of anti-TNF-α Ab. Interestingly, IL-2 and IL- 7, which utilize some IL-15R components, had no effect on osteoclast differentiation, but pretreatment with IL-2 or IL-7 of bone marrow cells before the addition of IL-15 inhibited the enhancing activity of IL-15. In summary, IL-15 has a novel activity to stimulate the differentiation of osteoclast progenitors into preosteoclasts, which cannot be replaced by IL-2 but may use components in common with IL-2R to mediate its effects.",
author = "Yoshiyasu Ogata and Akiko Kukita and Toshio Kukita and Mitunori Komine and Akira Miyahara and Sumio Miyazaki and Osamu Kohashi",
year = "1999",
month = "3",
day = "1",
language = "English",
volume = "162",
pages = "2754--2760",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - A novel role of IL-15 in the development of osteoclasts

T2 - Inability to replace its activity with IL-2

AU - Ogata, Yoshiyasu

AU - Kukita, Akiko

AU - Kukita, Toshio

AU - Komine, Mitunori

AU - Miyahara, Akira

AU - Miyazaki, Sumio

AU - Kohashi, Osamu

PY - 1999/3/1

Y1 - 1999/3/1

N2 - IL-15 shares many activities with IL-2 on stimulating lymphocytes, hematopoietic progenitor cells, and macrophages. However, the role of IL-15 in osteoclastogenesis has not been elucidated. The recent finding of abundant IL-15 in rheumatoid arthritis synovial fluids suggested a possible role for this cytokine in the pathological destruction of bone and prompted us to determine whether IL-15 stimulates osteoclast formation. IL-15 stimulated the formation of multinucleated osteoclast-like cells in rat bone marrow cultures. In stroma-free cultures, IL-15 increased the number of mononuclear preosteoclast-like cells in the early stage of osteoclast formation. The stimulation was observed even after treatment with IL-15 for only 24 or 48 h of culture. Moreover, low IL-15 concentration (0.1 ng/ml) strongly increased the level of calcitonin receptor mRNA of mononuclear preosteoclast-like cells. Although IL-15 is known as a potent stimulator of TNF-α, its activity was not abolished by addition of anti-TNF-α Ab. Interestingly, IL-2 and IL- 7, which utilize some IL-15R components, had no effect on osteoclast differentiation, but pretreatment with IL-2 or IL-7 of bone marrow cells before the addition of IL-15 inhibited the enhancing activity of IL-15. In summary, IL-15 has a novel activity to stimulate the differentiation of osteoclast progenitors into preosteoclasts, which cannot be replaced by IL-2 but may use components in common with IL-2R to mediate its effects.

AB - IL-15 shares many activities with IL-2 on stimulating lymphocytes, hematopoietic progenitor cells, and macrophages. However, the role of IL-15 in osteoclastogenesis has not been elucidated. The recent finding of abundant IL-15 in rheumatoid arthritis synovial fluids suggested a possible role for this cytokine in the pathological destruction of bone and prompted us to determine whether IL-15 stimulates osteoclast formation. IL-15 stimulated the formation of multinucleated osteoclast-like cells in rat bone marrow cultures. In stroma-free cultures, IL-15 increased the number of mononuclear preosteoclast-like cells in the early stage of osteoclast formation. The stimulation was observed even after treatment with IL-15 for only 24 or 48 h of culture. Moreover, low IL-15 concentration (0.1 ng/ml) strongly increased the level of calcitonin receptor mRNA of mononuclear preosteoclast-like cells. Although IL-15 is known as a potent stimulator of TNF-α, its activity was not abolished by addition of anti-TNF-α Ab. Interestingly, IL-2 and IL- 7, which utilize some IL-15R components, had no effect on osteoclast differentiation, but pretreatment with IL-2 or IL-7 of bone marrow cells before the addition of IL-15 inhibited the enhancing activity of IL-15. In summary, IL-15 has a novel activity to stimulate the differentiation of osteoclast progenitors into preosteoclasts, which cannot be replaced by IL-2 but may use components in common with IL-2R to mediate its effects.

UR - http://www.scopus.com/inward/record.url?scp=0033104735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033104735&partnerID=8YFLogxK

M3 - Article

C2 - 10072521

AN - SCOPUS:0033104735

VL - 162

SP - 2754

EP - 2760

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -